Lorin Roskos
Impact in
- Oncology top 2%
- Neutropenia and Cancer Infections
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- HER2/EGFR in Cancer Research
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 48
- Immunology 42
- Biosimilars and Bioanalytical Methods 24
- T-cell and B-cell Immunology 8
- Co-authors
- Mohammad Tabrizi (5 shared papers)Gisela Schwab (4 shared papers)Rajesh Narwal (21 shared papers)Bingbing Yang (5 shared papers)G Schwab (5 shared papers)Paolo Vicini (10 shared papers)Meina Liang (26 shared papers)R H Lévy (1 shared paper)
- Journals
- Journal of Clinical Oncology (14 papers)Journal of Immunological Methods (6 papers)Clinical Pharmacology & Therapeutics (6 papers)Annals of the Rheumatic Diseases (5 papers)The Journal of Clinical Pharmacology (4 papers)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Lorin Roskos
123 papers receiving 3.9k citations
Peers
Comparison fields: 5 of 129
- Oncology 1.3k
- Radiology, Nuclear Medicine and Imaging 964
- Immunology 887
- Pharmacology 321
- Hematology 380
Countries citing papers authored by Lorin Roskos
This map shows the geographic impact of Lorin Roskos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorin Roskos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorin Roskos more than expected).
Fields of papers citing papers by Lorin Roskos
This network shows the impact of papers produced by Lorin Roskos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorin Roskos. The network helps show where Lorin Roskos may publish in the future.
Co-authors
The 25 scholars most cited alongside Lorin Roskos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 127 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 369 | |
| 2 | 2000 | 212 | |
| 3 | 2000 | 181 | |
| 4 | 2004 | 177 | |
| 5 | 1996 | 172 | |
| 6 | 1996 | 172 | |
| 7 | 2007 | 155 | |
| 8 | 2012 | 117 | |
| 9 | 2017 | 116 | |
| 10 | 2017 | 114 | |
| 11 | 2006 | 98 | |
| 12 | 2004 | 75 | |
| 13 | 2019 | 73 | |
| 14 | 2006 | 71 | |
| 15 | 2004 | 71 | |
| 16 | 2015 | 68 | |
| 17 | 2007 | 66 | |
| 18 | 2010 | 62 | |
| 19 | 2018 | 57 | |
| 20 | 2010 | 55 |
About Lorin Roskos
Lorin Roskos is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology, Oncology, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 127 papers that have together received 4.1k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (48 papers), Biosimilars and Bioanalytical Methods (24 papers), Cancer Immunotherapy and Biomarkers (16 papers), Chronic Lymphocytic Leukemia Research (10 papers), T-cell and B-cell Immunology (8 papers), Systemic Lupus Erythematosus Research (8 papers), HER2/EGFR in Cancer Research (7 papers) and Platelet Disorders and Treatments (7 papers). The work is most often cited by research in Oncology (1.3k citations), Radiology, Nuclear Medicine and Imaging (964 citations), Immunology (887 citations), Pharmacology (321 citations) and Hematology (380 citations). Lorin Roskos has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Mohammad Tabrizi, Gisela Schwab, Rajesh Narwal, Bingbing Yang, G Schwab, Paolo Vicini, Meina Liang, R H Lévy, Manoj Bajpai and Dongbei Shen. Their work appears in journals such as Journal of Clinical Oncology, Journal of Immunological Methods, Clinical Pharmacology & Therapeutics, Annals of the Rheumatic Diseases and The Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.